Safety, Tolerability, and Efficacy of PresbiDrops (CSF-1), a Topical Ophthalmic Drug for Presbyopia

NCT02745223 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Presbyopia

Interventions

DRUG: PresbiDrops (CSF-1)
DRUG: Placebo

Sponsor

Orasis Pharmaceuticals Ltd.